Clinical Trials

Making big strides in the treatment of small cell lung cancer. Plus, how to manage your diabetes with confidence.

Small cell lung cancer (SCLC) stands as a formidable adversary in the realm of oncology, representing a highly aggressive form of lung cancer notorious for its rapid growth and propensity to metastasize early.

Clinical trials—they offer new and potentially life-changing medicines that are tested by top physicians for subsequent approval by the FDA—ultimately helping those who need them the most. An important research study for Alzheimer’s is currently taking place at Charter Research in Central Florida. Alzheimer’s is the 5th leading cause of death in adults 65 and […]

We sat down with John Hood, co-founder, and CEO of Endeavor BioMedicines, to hear about their focus on precision medicine and more.

NRG1 fusions, a rare cancer target, may unlock new potential options for doctors and patients.

In the United States, sickle cell disease affects an estimated 100,000 people. Patients with severe sickle cell have a very poor quality of life, with frequent pain episodes and trips to the hospital.

Learn about how the gut can play a role in serious kidney disease. Plus, what you need to know about sickle cell anemia.

Join us as The Balancing Act discusses lupus and lupus nephritis with Dr. William Pendergraft from UNC Kidney Center.

This episode of The Balancing Act focuses on two very different diseases: Lupus and Plasminogen Deficiency (PLGD).